Jamilu Tukur1. 1. Department of Obstetrics and Gynaecology, Aminu Kano Teaching Hospital/ Bayero University, Kano, Nigeria. jtukur@yahoo.com
Abstract
BACKGROUND: Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant. METHOD: In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate. RESULTS: The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported. CONCLUSION: A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.
BACKGROUND: Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant. METHOD: In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate. RESULTS: The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported. CONCLUSION: A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.
Authors: Sara Houlihan; Diane Decarie; Cindy Benes; Richard Cleve; Marianne Vidler; Laura A Magee; Mary H H Ensom; Peter von Dadelszen Journal: J Obstet Gynaecol Can Date: 2016-06-29
Authors: Jeffrey Michael Smith; Richard F Lowe; Judith Fullerton; Sheena M Currie; Laura Harris; Erica Felker-Kantor Journal: BMC Pregnancy Childbirth Date: 2013-02-05 Impact factor: 3.007